{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T02:54:19Z","timestamp":1771383259136,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.jaad.2004.10.888","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T07:21:02Z","timestamp":1129620062000},"page":"S240-S243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"S","title":["Pityriasis rosea\u2013like eruption during treatment with imatinib mesylate: Description of 3 cases"],"prefix":"10.1016","volume":"53","author":[{"given":"Valeria","family":"Brazzelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Prestinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Roveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Bellani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2004.10.888_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.888_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/shem.2003.50034","article-title":"Molecular mechanism of transformation by the bcr-abl oncogene","volume":"40","author":"Sattler","year":"2003","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaad.2004.10.888_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukaemia","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.888_bib4","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the bcr-abl tyrosine kinase in the blast crisis of chronic myeloid leukaemia and acute lymphoblastic leukaemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.888_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.2002.20.1.325","article-title":"STI571: A paradigm of new agents for cancer therapeutics","volume":"20","author":"Mauro","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.10.888_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM200108233450814","article-title":"Cutaneous reactions to STI571","volume":"345","author":"Brouard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2004.10.888_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1067\/mjd.2003.44","article-title":"Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients","volume":"48","author":"Valeyrie","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2004.10.888_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000051705","article-title":"Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukaemia","volume":"203","author":"Brouard","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.888_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0609.2002.02830.x","article-title":"Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukaemia","volume":"69","author":"Schwarz","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaad.2004.10.888_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.0303-6987.2003.053.x","article-title":"Mycosis fungoides-like reactions in a patient treated with Gleevec","volume":"30","author":"Clark","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2004.10.888_bib11","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2002.03499.x","article-title":"Steven-Johnson syndrome after treatment with STI571: a case report","volume":"117","author":"Hsiao","year":"2002","journal-title":"Br J Hematol"},{"key":"10.1016\/j.jaad.2004.10.888_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000063899","article-title":"Oral lichenoid reaction to Imatimib (STI571, Gleevec)","volume":"205","author":"Lim","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.888_bib13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2002.20.3.869","article-title":"Depigmentation in a chronic myeloid leucemia patient treated with STI-571","volume":"20","author":"Raanani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2004.10.888_bib14","first-page":"722","article-title":"Hypopigmentation in an African patient treated with imatinib mesylate: a case report","volume":"95","author":"Hasan","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jaad.2004.10.888_bib15","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/cncr.11812","article-title":"Imatinib mesylate causes hypopigmentation in the skin","volume":"98","author":"Tsao","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2004.10.888_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000063900","article-title":"Pityriasis rosea associated with imatinib (STI571, Gleevec)","volume":"205","author":"Konstantopoulos","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.888_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1525-1470.1995.tb00130.x","article-title":"Atypical pityriasis rosea in a 2-year-old","volume":"12","author":"Repiso","year":"1995","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2004.10.888_bib18","series-title":"Histologic diagnosis of inflammatory skin diseases","first-page":"623","year":"1997"},{"key":"10.1016\/j.jaad.2004.10.888_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00015550152572958","article-title":"Human herpes virus 6 and 7 DNA in peripheral blood leucocytes and plasma in patients with pityriasis rosea by polymerase chain reaction: a prospective case control study","volume":"81","author":"Chuh","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2004.10.888_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000018439","article-title":"Pityriasis-rosea-like eruption due to Benfluorex","volume":"201","author":"Loche","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2004.10.888_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000249451","article-title":"Pityriasis rosea and Ketotifen","volume":"171","author":"Wolf","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2004.10.888_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2133.1996.tb03863.x","article-title":"Pityriasis rosea-like eruption in a patient receiving omeprazole","volume":"135","author":"Buckley","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2004.10.888_bib23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1177\/42.11.7523489","article-title":"Expression of c-kit and kit ligands proteins in normal human tissues","volume":"42","author":"Lammie","year":"1994","journal-title":"J Histochem Cytochem"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205010285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205010285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:38:00Z","timestamp":1759268280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205010285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0190962205010285"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2004.10.888","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis rosea\u2013like eruption during treatment with imatinib mesylate: Description of 3 cases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2004.10.888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}